{"transactions":[{"id":3679675,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-09-09T00:02:03.000Z","date":"2026-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":22025,"price":22.22,"value":489395.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025."}],"balance_after":115519,"source":{"system":"sec-edgar","filing":"0001193125-26-385541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046214/000119312526385541/ownership.xml","form_type":"4"}},{"id":844800,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-14T00:01:03.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":974,"price":17.03,"value":16587.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025."}],"balance_after":137544,"source":{"system":"sec-edgar","filing":"0001193125-26-106697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106697/ownership.xml","form_type":"4"}},{"id":849650,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-12T00:07:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":346,"price":16.95,"value":5864.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":138518,"source":{"system":"sec-edgar","filing":"0001193125-26-102708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102708/ownership.xml","form_type":"4"}},{"id":849649,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-12T00:07:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":484,"price":16.95,"value":8203.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":138864,"source":{"system":"sec-edgar","filing":"0001193125-26-102708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102708/ownership.xml","form_type":"4"}},{"id":871304,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-04T01:07:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":408,"price":16.2,"value":6609.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."}],"balance_after":139348,"source":{"system":"sec-edgar","filing":"0001193125-26-089439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089439/ownership.xml","form_type":"4"}},{"id":984311,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-12-03T01:02:03.000Z","date":"2025-11-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":229,"price":21.12,"value":4836.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 26, 2024."}],"balance_after":139756,"source":{"system":"sec-edgar","filing":"0001193125-25-305662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525305662/ownership.xml","form_type":"4"}},{"id":1047163,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:03.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board."}],"balance_after":139985,"source":{"system":"sec-edgar","filing":"0001193125-25-197422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197422/ownership.xml","form_type":"4"}},{"id":1047162,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:03.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":93875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company."}],"balance_after":114985,"source":{"system":"sec-edgar","filing":"0001193125-25-197422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197422/ownership.xml","form_type":"4"}},{"id":1213619,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":16644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":16644,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":16644},"source":{"system":"sec-edgar","filing":"0000950170-25-037527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037527/ownership.xml","form_type":"4"}},{"id":1213618,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":8276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":21110,"source":{"system":"sec-edgar","filing":"0000950170-25-037527","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037527/ownership.xml","form_type":"4"}},{"id":1213617,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":491,"price":100.13,"value":49163.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":12834,"source":{"system":"sec-edgar","filing":"0000950170-25-037527","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037527/ownership.xml","form_type":"4"}},{"id":1216327,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:06.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":347,"price":103.7,"value":35983.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":11847,"source":{"system":"sec-edgar","filing":"0000950170-25-036693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036693/ownership.xml","form_type":"4"}},{"id":1216326,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:06.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1131,"price":103.7,"value":117284.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023."}],"balance_after":12194,"source":{"system":"sec-edgar","filing":"0000950170-25-036693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036693/ownership.xml","form_type":"4"}},{"id":1220735,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-07T01:00:09.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":296,"price":101.34,"value":29996.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":13325,"source":{"system":"sec-edgar","filing":"0000950170-25-035006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025035006/ownership.xml","form_type":"4"}},{"id":1220734,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-07T01:00:09.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":288,"price":101.34,"value":29185.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":13037,"source":{"system":"sec-edgar","filing":"0000950170-25-035006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025035006/ownership.xml","form_type":"4"}},{"id":1232455,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T01:00:03.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":391,"price":103.77,"value":40574.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 195 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025."}],"balance_after":13621,"source":{"system":"sec-edgar","filing":"0000950170-25-032758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025032758/ownership.xml","form_type":"4"}},{"id":1348622,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-30T01:15:04.000Z","date":"2024-11-26","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":4000,"derivative":{"exercise_price":130.5,"exercise_date":"2025-11-26","expiration_date":"2034-11-26","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-24-131938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024131938/ownership.xml","form_type":"4"}},{"id":1348621,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-11-30T01:15:04.000Z","date":"2024-11-26","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":13817,"source":{"system":"sec-edgar","filing":"0000950170-24-131938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024131938/ownership.xml","form_type":"4"}}]}